Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians.
Sirolimus-eluting stent (SES) implantation has been shown to reduce repeat revascularization in various randomized trials. The present study evaluated the outcomes after SES implantation in 46 octogenarian patients. SES implantation in octogenarians appears to be feasible and is associated with very small subsequent need for repeat target vessel revascularization at 1 year.
Vijayakumar
Maniyal
M
Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands.
Lemos
Pedro A
PA
Hoye
Angela
A
Ong
Andrew T L
AT
Aoki
Jiro
J
Granillo
Gaston Rodriguez
GR
McFadden
Eugene P
EP
Sianos
Georgios
G
Hofma
Sjoerd H
SH
Smits
Pieter C
PC
van der Giessen
Willem J
WJ
de Feyter
Pim
P
van Domburg
Ron T
RT
Cummins
Paul A
PA
Serruys
Patrick W
PW
D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary; D019917:Blood Vessel Prosthesis Implantation; D020099:Coated Materials, Biocompatible / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003324:Coronary Artery Disease / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D017052:Hospital Mortality; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D009426:Netherlands; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D011183:Postoperative Complications / Q000209:etiology / Q000401:mortality; D020123:Sirolimus / Q000627:therapeutic use*; D015607:Stents; D016896:Treatment Outcome
D020099:Coated Materials, Biocompatible; D007166:Immunosuppressive Agents; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D020123:Sirolimus